title: Use of Androgen Deprivation Therapy With Radiotherapy for Intermediate- and High-Risk Prostate Cancer Across the United States.
authors.affiliation: Department of Radiation Oncology, University of North Carolina at Chapel Hill, Chapel Hill.
authors.forename: Aaron D
authors.initials: AD
authors.lastname: Falchook
authors.affiliation: Department of Radiation Oncology, University of North Carolina at Chapel Hill, Chapel Hill.
authors.forename: Ramsankar
authors.initials: R
authors.lastname: Basak
authors.affiliation: Department of Radiation Oncology, University of North Carolina at Chapel Hill, Chapel Hill.
authors.forename: Jahan J
authors.initials: JJ
authors.lastname: Mohiuddin
authors.affiliation: Department of Radiation Oncology, University of North Carolina at Chapel Hill, Chapel Hill2University of North Carolina-Lineberger Comprehensive Cancer Center, Chapel Hill.
authors.forename: Ronald C
authors.initials: RC
authors.lastname: Chen
mesh_terms: D000726:Androgen Antagonists / Q000627:therapeutic use*; D003131:Combined Modality Therapy; D016208:Databases, Factual; D005843:Geography; D006801:Humans; D008297:Male; D015999:Multivariate Analysis; D060787:Neoplasm Grading; D016017:Odds Ratio; D010818:Practice Patterns, Physicians' / Q000706:statistics & numerical data*; D011471:Prostatic Neoplasms / Q000473:pathology / Q000628:therapy*; D011878:Radiotherapy / Q000706:statistics & numerical data*; D011879:Radiotherapy Dosage; D014481:United States
chemical_list: D000726:Androgen Antagonists